nodes	percent_of_prediction	percent_of_DWPC	metapath
Azacitidine—DNMT3A—hematologic cancer	0.0758	0.529	CbGaD
Azacitidine—Nucleic Acid Synthesis Inhibitors—Nelarabine—hematologic cancer	0.0683	0.235	CiPCiCtD
Azacitidine—Nucleic Acid Synthesis Inhibitors—Pentostatin—hematologic cancer	0.0683	0.235	CiPCiCtD
Azacitidine—Nucleic Acid Synthesis Inhibitors—Clofarabine—hematologic cancer	0.0683	0.235	CiPCiCtD
Azacitidine—CDA—hematologic cancer	0.0676	0.471	CbGaD
Azacitidine—CDA—Cytarabine—hematologic cancer	0.0597	0.622	CbGbCtD
Azacitidine—Nucleic Acid Synthesis Inhibitors—Cytarabine—hematologic cancer	0.0517	0.178	CiPCiCtD
Azacitidine—Pentostatin—hematologic cancer	0.0453	0.192	CrCtD
Azacitidine—Clofarabine—hematologic cancer	0.0404	0.171	CrCtD
Azacitidine—Nelarabine—hematologic cancer	0.038	0.16	CrCtD
Azacitidine—CDA—Gemcitabine—hematologic cancer	0.0364	0.378	CbGbCtD
Azacitidine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—hematologic cancer	0.0333	0.115	CiPCiCtD
Azacitidine—Fludarabine—hematologic cancer	0.0296	0.125	CrCtD
Azacitidine—Gemcitabine—hematologic cancer	0.028	0.118	CrCtD
Azacitidine—Cytarabine—hematologic cancer	0.028	0.118	CrCtD
Azacitidine—Cladribine—hematologic cancer	0.0273	0.115	CrCtD
Azacitidine—Gemcitabine—Cytarabine—hematologic cancer	0.00464	0.0299	CrCrCtD
Azacitidine—Adenosine triphosphate—Nelarabine—hematologic cancer	0.00362	0.0233	CrCrCtD
Azacitidine—Ribavirin—Clofarabine—hematologic cancer	0.00356	0.023	CrCrCtD
Azacitidine—Glucosamine—Cytarabine—hematologic cancer	0.00355	0.0229	CrCrCtD
Azacitidine—Ribavirin—Nelarabine—hematologic cancer	0.00335	0.0216	CrCrCtD
Azacitidine—Regadenoson—Clofarabine—hematologic cancer	0.00332	0.0214	CrCrCtD
Azacitidine—S-Adenosylmethionine—Clofarabine—hematologic cancer	0.00332	0.0214	CrCrCtD
Azacitidine—Regadenoson—Nelarabine—hematologic cancer	0.00313	0.0202	CrCrCtD
Azacitidine—S-Adenosylmethionine—Nelarabine—hematologic cancer	0.00313	0.0202	CrCrCtD
Azacitidine—Clofarabine—Nelarabine—hematologic cancer	0.00313	0.0202	CrCrCtD
Azacitidine—Fludarabine—Clofarabine—hematologic cancer	0.00312	0.0201	CrCrCtD
Azacitidine—Adenosine—Pentostatin—hematologic cancer	0.00296	0.0191	CrCrCtD
Azacitidine—Vidarabine—Pentostatin—hematologic cancer	0.00296	0.0191	CrCrCtD
Azacitidine—Cladribine—Pentostatin—hematologic cancer	0.00296	0.0191	CrCrCtD
Azacitidine—Adenosine monophosphate—Clofarabine—hematologic cancer	0.00294	0.0189	CrCrCtD
Azacitidine—Nelarabine—Clofarabine—hematologic cancer	0.00294	0.0189	CrCrCtD
Azacitidine—Fludarabine—Nelarabine—hematologic cancer	0.00293	0.0189	CrCrCtD
Azacitidine—Pentostatin—Cladribine—hematologic cancer	0.00283	0.0182	CrCrCtD
Azacitidine—Adenosine triphosphate—Fludarabine—hematologic cancer	0.00282	0.0182	CrCrCtD
Azacitidine—Decitabine—Pentostatin—hematologic cancer	0.00282	0.0182	CrCrCtD
Azacitidine—Cytarabine—Clofarabine—hematologic cancer	0.00278	0.0179	CrCrCtD
Azacitidine—Adenosine monophosphate—Nelarabine—hematologic cancer	0.00276	0.0178	CrCrCtD
Azacitidine—Adenosine—Clofarabine—hematologic cancer	0.00264	0.017	CrCrCtD
Azacitidine—Cladribine—Clofarabine—hematologic cancer	0.00264	0.017	CrCrCtD
Azacitidine—Vidarabine—Clofarabine—hematologic cancer	0.00264	0.017	CrCrCtD
Azacitidine—Ribavirin—Fludarabine—hematologic cancer	0.00262	0.0169	CrCrCtD
Azacitidine—Cytarabine—Nelarabine—hematologic cancer	0.00262	0.0169	CrCrCtD
Azacitidine—Decitabine—Clofarabine—hematologic cancer	0.00252	0.0162	CrCrCtD
Azacitidine—Vidarabine—Nelarabine—hematologic cancer	0.00248	0.016	CrCrCtD
Azacitidine—Cladribine—Nelarabine—hematologic cancer	0.00248	0.016	CrCrCtD
Azacitidine—Adenosine—Nelarabine—hematologic cancer	0.00248	0.016	CrCrCtD
Azacitidine—Ribavirin—Cytarabine—hematologic cancer	0.00247	0.0159	CrCrCtD
Azacitidine—Regadenoson—Fludarabine—hematologic cancer	0.00244	0.0157	CrCrCtD
Azacitidine—S-Adenosylmethionine—Fludarabine—hematologic cancer	0.00244	0.0157	CrCrCtD
Azacitidine—Clofarabine—Fludarabine—hematologic cancer	0.00244	0.0157	CrCrCtD
Azacitidine—Decitabine—Nelarabine—hematologic cancer	0.00237	0.0152	CrCrCtD
Azacitidine—Regadenoson—Cytarabine—hematologic cancer	0.0023	0.0149	CrCrCtD
Azacitidine—S-Adenosylmethionine—Cytarabine—hematologic cancer	0.0023	0.0149	CrCrCtD
Azacitidine—Clofarabine—Cytarabine—hematologic cancer	0.0023	0.0149	CrCrCtD
Azacitidine—Clofarabine—Cladribine—hematologic cancer	0.00225	0.0145	CrCrCtD
Azacitidine—Regadenoson—Cladribine—hematologic cancer	0.00225	0.0145	CrCrCtD
Azacitidine—Fludarabine—Cytarabine—hematologic cancer	0.00216	0.0139	CrCrCtD
Azacitidine—Adenosine monophosphate—Fludarabine—hematologic cancer	0.00216	0.0139	CrCrCtD
Azacitidine—Nelarabine—Fludarabine—hematologic cancer	0.00216	0.0139	CrCrCtD
Azacitidine—Fludarabine—Cladribine—hematologic cancer	0.00211	0.0136	CrCrCtD
Azacitidine—Cytarabine—Fludarabine—hematologic cancer	0.00204	0.0132	CrCrCtD
Azacitidine—Adenosine monophosphate—Cytarabine—hematologic cancer	0.00204	0.0131	CrCrCtD
Azacitidine—Nelarabine—Cytarabine—hematologic cancer	0.00204	0.0131	CrCrCtD
Azacitidine—Adenosine monophosphate—Cladribine—hematologic cancer	0.00199	0.0128	CrCrCtD
Azacitidine—Nelarabine—Cladribine—hematologic cancer	0.00199	0.0128	CrCrCtD
Azacitidine—Adenosine—Fludarabine—hematologic cancer	0.00194	0.0125	CrCrCtD
Azacitidine—Vidarabine—Fludarabine—hematologic cancer	0.00194	0.0125	CrCrCtD
Azacitidine—Cladribine—Fludarabine—hematologic cancer	0.00194	0.0125	CrCrCtD
Azacitidine—Cytarabine—Gemcitabine—hematologic cancer	0.00193	0.0124	CrCrCtD
Azacitidine—Adenosine—Cytarabine—hematologic cancer	0.00183	0.0118	CrCrCtD
Azacitidine—Vidarabine—Cytarabine—hematologic cancer	0.00183	0.0118	CrCrCtD
Azacitidine—Vidarabine—Cladribine—hematologic cancer	0.00178	0.0115	CrCrCtD
Azacitidine—Adenosine—Cladribine—hematologic cancer	0.00178	0.0115	CrCrCtD
Azacitidine—Decitabine—Gemcitabine—hematologic cancer	0.00174	0.0112	CrCrCtD
Azacitidine—Decitabine—Cytarabine—hematologic cancer	0.00174	0.0112	CrCrCtD
Azacitidine—Decitabine—Cladribine—hematologic cancer	0.0017	0.011	CrCrCtD
Azacitidine—DNMT3A—hematopoietic system—hematologic cancer	0.000992	0.102	CbGeAlD
Azacitidine—CDA—hematopoietic system—hematologic cancer	0.000938	0.0965	CbGeAlD
Azacitidine—DNMT3A—gonad—hematologic cancer	0.000754	0.0776	CbGeAlD
Azacitidine—DNMT3A—blood—hematologic cancer	0.000657	0.0676	CbGeAlD
Azacitidine—CDA—blood—hematologic cancer	0.000621	0.0639	CbGeAlD
Azacitidine—CDA—bone marrow—hematologic cancer	0.000601	0.0619	CbGeAlD
Azacitidine—DNMT1—hematopoietic system—hematologic cancer	0.0006	0.0617	CbGeAlD
Azacitidine—DNMT3A—lung—hematologic cancer	0.000576	0.0593	CbGeAlD
Azacitidine—DNMT3A—testis—hematologic cancer	0.000544	0.0559	CbGeAlD
Azacitidine—CDA—testis—hematologic cancer	0.000514	0.0529	CbGeAlD
Azacitidine—DNMT1—gonad—hematologic cancer	0.000456	0.0469	CbGeAlD
Azacitidine—DNMT1—blood—hematologic cancer	0.000398	0.0409	CbGeAlD
Azacitidine—DNMT3A—lymph node—hematologic cancer	0.000394	0.0406	CbGeAlD
Azacitidine—DNMT1—bone marrow—hematologic cancer	0.000385	0.0396	CbGeAlD
Azacitidine—CDA—lymph node—hematologic cancer	0.000373	0.0383	CbGeAlD
Azacitidine—DNMT1—lung—hematologic cancer	0.000349	0.0359	CbGeAlD
Azacitidine—DNMT1—testis—hematologic cancer	0.000329	0.0338	CbGeAlD
Azacitidine—DNMT1—lymph node—hematologic cancer	0.000238	0.0245	CbGeAlD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—ID2—hematologic cancer	0.000223	0.0108	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—ABCG2—hematologic cancer	0.000211	0.0103	CbGpPWpGaD
Azacitidine—DNMT1—Trans-sulfuration and one carbon metabolism—DNMT3A—hematologic cancer	0.00021	0.0102	CbGpPWpGaD
Azacitidine—DNMT1—One Carbon Metabolism—DNMT3B—hematologic cancer	0.0002	0.00969	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—SPI1—hematologic cancer	0.000191	0.00929	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—ARID4A—hematologic cancer	0.00019	0.00924	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—CEBPD—hematologic cancer	0.00019	0.0092	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—CEBPA—hematologic cancer	0.00019	0.0092	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—CFLAR—hematologic cancer	0.00019	0.0092	CbGpPWpGaD
Azacitidine—DNMT3A—RMTs methylate histone arginines—ARID1A—hematologic cancer	0.000185	0.00898	CbGpPWpGaD
Azacitidine—DNMT1—Trans-sulfuration and one carbon metabolism—DNMT3B—hematologic cancer	0.000179	0.00871	CbGpPWpGaD
Azacitidine—DNMT1—One Carbon Metabolism—MTR—hematologic cancer	0.00017	0.00824	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—DCK—hematologic cancer	0.000162	0.00786	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—SMUG1—hematologic cancer	0.000162	0.00785	CbGpPWpGaD
Azacitidine—DNMT3A—DNA methylation—DNMT3B—hematologic cancer	0.000157	0.0076	CbGpPWpGaD
Azacitidine—DNMT3A—DNA methylation—H3F3B—hematologic cancer	0.000157	0.0076	CbGpPWpGaD
Azacitidine—DNMT1—Trans-sulfuration and one carbon metabolism—MTR—hematologic cancer	0.000153	0.00741	CbGpPWpGaD
Azacitidine—DNMT3A—PRC2 methylates histones and DNA—DNMT3B—hematologic cancer	0.000142	0.00689	CbGpPWpGaD
Azacitidine—DNMT3A—PRC2 methylates histones and DNA—H3F3B—hematologic cancer	0.000142	0.00689	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—DKK1—hematologic cancer	0.00014	0.00681	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—IRF8—hematologic cancer	0.000135	0.00656	CbGpPWpGaD
Azacitidine—DNMT3A—One Carbon Metabolism—MTHFR—hematologic cancer	0.000135	0.00653	CbGpPWpGaD
Azacitidine—CDA—Nucleotide metabolism—TXN—hematologic cancer	0.00013	0.00632	CbGpPWpGaD
Azacitidine—DNMT1—DNA methylation—DNMT3A—hematologic cancer	0.000124	0.00601	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CEBPA—hematologic cancer	0.000123	0.00599	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CEBPD—hematologic cancer	0.000123	0.00599	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—KAT6A—hematologic cancer	0.000123	0.00596	CbGpPWpGaD
Azacitidine—DNMT3A—Trans-sulfuration and one carbon metabolism—MTHFR—hematologic cancer	0.000121	0.00587	CbGpPWpGaD
Azacitidine—DNMT3A—Epigenetic regulation of gene expression—TET2—hematologic cancer	0.00012	0.00583	CbGpPWpGaD
Azacitidine—DNMT3A—DNA methylation—H3F3A—hematologic cancer	0.000117	0.0057	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—MTHFR—hematologic cancer	0.000113	0.00549	CbGpPWpGaD
Azacitidine—DNMT1—PRC2 methylates histones and DNA—DNMT3A—hematologic cancer	0.000112	0.00545	CbGpPWpGaD
Azacitidine—DNMT3A—RMTs methylate histone arginines—SMARCA4—hematologic cancer	0.000111	0.00541	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—SMC3—hematologic cancer	0.000111	0.00539	CbGpPWpGaD
Azacitidine—Decitabine—DNMT3A—hematologic cancer	0.00011	0.0949	CrCbGaD
Azacitidine—DNMT3A—PRC2 methylates histones and DNA—H3F3A—hematologic cancer	0.000107	0.00517	CbGpPWpGaD
Azacitidine—DNMT1—DNA methylation—DNMT3B—hematologic cancer	0.000106	0.00513	CbGpPWpGaD
Azacitidine—DNMT1—DNA methylation—H3F3B—hematologic cancer	0.000106	0.00513	CbGpPWpGaD
Azacitidine—DNMT3A—PRC2 methylates histones and DNA—EZH2—hematologic cancer	0.000102	0.00496	CbGpPWpGaD
Azacitidine—DNMT1—PRC2 methylates histones and DNA—DNMT3B—hematologic cancer	9.59e-05	0.00466	CbGpPWpGaD
Azacitidine—DNMT1—PRC2 methylates histones and DNA—H3F3B—hematologic cancer	9.59e-05	0.00466	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CCND3—hematologic cancer	9.51e-05	0.00462	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—HDAC10—hematologic cancer	9.3e-05	0.00451	CbGpPWpGaD
Azacitidine—DNMT3A—Epigenetic regulation of gene expression—DNMT3B—hematologic cancer	9.11e-05	0.00442	CbGpPWpGaD
Azacitidine—DNMT3A—Epigenetic regulation of gene expression—H3F3B—hematologic cancer	9.11e-05	0.00442	CbGpPWpGaD
Azacitidine—DNMT1—One Carbon Metabolism—MTHFR—hematologic cancer	9.09e-05	0.00441	CbGpPWpGaD
Azacitidine—Decitabine—DCK—hematologic cancer	8.6e-05	0.0745	CrCbGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—ARID5B—hematologic cancer	8.51e-05	0.00413	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—CDKN2B—hematologic cancer	8.39e-05	0.00407	CbGpPWpGaD
Azacitidine—Gemcitabine—CDA—hematologic cancer	8.37e-05	0.0725	CrCbGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—SMARCA4—hematologic cancer	8.33e-05	0.00404	CbGpPWpGaD
Azacitidine—Nelarabine—DCK—hematologic cancer	8.28e-05	0.0717	CrCbGaD
Azacitidine—DNMT1—Trans-sulfuration and one carbon metabolism—MTHFR—hematologic cancer	8.17e-05	0.00397	CbGpPWpGaD
Azacitidine—DNMT1—Epigenetic regulation of gene expression—TET2—hematologic cancer	8.12e-05	0.00394	CbGpPWpGaD
Azacitidine—Clofarabine—DCK—hematologic cancer	8.06e-05	0.0698	CrCbGaD
Azacitidine—DNMT1—Vinblastine—Vinorelbine—hematologic cancer	8.01e-05	0.123	CbGdCrCtD
Azacitidine—DNMT1—DNA methylation—H3F3A—hematologic cancer	7.93e-05	0.00385	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—ARID1A—hematologic cancer	7.91e-05	0.00384	CbGpPWpGaD
Azacitidine—Fludarabine—DCK—hematologic cancer	7.8e-05	0.0676	CrCbGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—PDGFRB—hematologic cancer	7.74e-05	0.00376	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CCND3—hematologic cancer	7.62e-05	0.0037	CbGpPWpGaD
Azacitidine—Gemcitabine—DCK—hematologic cancer	7.37e-05	0.0638	CrCbGaD
Azacitidine—DNMT1—PRC2 methylates histones and DNA—H3F3A—hematologic cancer	7.2e-05	0.00349	CbGpPWpGaD
Azacitidine—DNMT1—Epigenetic regulation of gene expression—DNMT3A—hematologic cancer	7.2e-05	0.00349	CbGpPWpGaD
Azacitidine—DNMT1—NoRC negatively regulates rRNA expression—DNMT3B—hematologic cancer	7.1e-05	0.00345	CbGpPWpGaD
Azacitidine—DNMT1—NoRC negatively regulates rRNA expression—H3F3B—hematologic cancer	7.1e-05	0.00345	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CDK6—hematologic cancer	7.09e-05	0.00344	CbGpPWpGaD
Azacitidine—DNMT1—Negative epigenetic regulation of rRNA expression—DNMT3B—hematologic cancer	6.94e-05	0.00337	CbGpPWpGaD
Azacitidine—DNMT1—Negative epigenetic regulation of rRNA expression—H3F3B—hematologic cancer	6.94e-05	0.00337	CbGpPWpGaD
Azacitidine—DNMT1—PRC2 methylates histones and DNA—EZH2—hematologic cancer	6.91e-05	0.00335	CbGpPWpGaD
Azacitidine—DNMT3A—Epigenetic regulation of gene expression—H3F3A—hematologic cancer	6.83e-05	0.00332	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—TSC2—hematologic cancer	6.69e-05	0.00325	CbGpPWpGaD
Azacitidine—DNMT3A—Epigenetic regulation of gene expression—EZH2—hematologic cancer	6.56e-05	0.00318	CbGpPWpGaD
Azacitidine—DNMT1—Vinblastine—Vincristine—hematologic cancer	6.4e-05	0.0984	CbGdCrCtD
Azacitidine—DNMT3A—Chromatin modifying enzymes—NCOR2—hematologic cancer	6.36e-05	0.00309	CbGpPWpGaD
Azacitidine—DNMT3A—Epigenetic regulation of gene expression—HDAC2—hematologic cancer	6.19e-05	0.003	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—SMC1A—hematologic cancer	6.17e-05	0.003	CbGpPWpGaD
Azacitidine—DNMT1—Epigenetic regulation of gene expression—DNMT3B—hematologic cancer	6.15e-05	0.00299	CbGpPWpGaD
Azacitidine—DNMT1—Epigenetic regulation of gene expression—H3F3B—hematologic cancer	6.15e-05	0.00299	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—TOP2A—hematologic cancer	6.11e-05	0.00297	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CCND2—hematologic cancer	6.09e-05	0.00296	CbGpPWpGaD
Azacitidine—Adenosine triphosphate—ASNS—hematologic cancer	5.9e-05	0.0511	CrCbGaD
Azacitidine—Cytarabine—CDA—hematologic cancer	5.71e-05	0.0495	CrCbGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CDK6—hematologic cancer	5.68e-05	0.00276	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—CREB1—hematologic cancer	5.63e-05	0.00273	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—ABL1—hematologic cancer	5.51e-05	0.00267	CbGpPWpGaD
Azacitidine—DNMT3A—RMTs methylate histone arginines—CDK4—hematologic cancer	5.46e-05	0.00265	CbGpPWpGaD
Azacitidine—DNMT1—NoRC negatively regulates rRNA expression—H3F3A—hematologic cancer	5.33e-05	0.00259	CbGpPWpGaD
Azacitidine—DNMT1—Negative epigenetic regulation of rRNA expression—H3F3A—hematologic cancer	5.2e-05	0.00253	CbGpPWpGaD
Azacitidine—Adenosine monophosphate—CREB1—hematologic cancer	5.16e-05	0.0447	CrCbGaD
Azacitidine—Glucosamine—IFNG—hematologic cancer	5.16e-05	0.0447	CrCbGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CSF2—hematologic cancer	5.12e-05	0.00249	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—ZNF552—hematologic cancer	5.04e-05	0.00245	CbGpPWpGaD
Azacitidine—Cytarabine—DCK—hematologic cancer	5.03e-05	0.0436	CrCbGaD
Azacitidine—DNMT1—NoRC negatively regulates rRNA expression—HDAC2—hematologic cancer	4.83e-05	0.00234	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—SMARCA4—hematologic cancer	4.76e-05	0.00231	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—BCL2—hematologic cancer	4.72e-05	0.00229	CbGpPWpGaD
Azacitidine—DNMT1—Negative epigenetic regulation of rRNA expression—HDAC2—hematologic cancer	4.71e-05	0.00229	CbGpPWpGaD
Azacitidine—Cladribine—DCK—hematologic cancer	4.63e-05	0.0401	CrCbGaD
Azacitidine—DNMT1—Epigenetic regulation of gene expression—H3F3A—hematologic cancer	4.62e-05	0.00224	CbGpPWpGaD
Azacitidine—DNMT3A—Amcinonide—Betamethasone—hematologic cancer	4.61e-05	0.0709	CbGdCrCtD
Azacitidine—DNMT3A—Amcinonide—Dexamethasone—hematologic cancer	4.61e-05	0.0709	CbGdCrCtD
Azacitidine—DNMT3A—Amcinonide—Triamcinolone—hematologic cancer	4.51e-05	0.0693	CbGdCrCtD
Azacitidine—Adenosine triphosphate—ABL2—hematologic cancer	4.47e-05	0.0387	CrCbGaD
Azacitidine—DNMT1—Epigenetic regulation of gene expression—EZH2—hematologic cancer	4.43e-05	0.00215	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—ABL1—hematologic cancer	4.42e-05	0.00214	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CDK2—hematologic cancer	4.32e-05	0.0021	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—TP53—hematologic cancer	4.3e-05	0.00209	CbGpPWpGaD
Azacitidine—DNMT3A—Amcinonide—Prednisone—hematologic cancer	4.28e-05	0.0657	CbGdCrCtD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—CDKN1B—hematologic cancer	4.25e-05	0.00206	CbGpPWpGaD
Azacitidine—DNMT1—Epigenetic regulation of gene expression—HDAC2—hematologic cancer	4.18e-05	0.00203	CbGpPWpGaD
Azacitidine—DNMT3A—Amcinonide—Prednisolone—hematologic cancer	4.17e-05	0.0642	CbGdCrCtD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—MAPK14—hematologic cancer	4.15e-05	0.00201	CbGpPWpGaD
Azacitidine—DNMT3A—RMTs methylate histone arginines—JAK2—hematologic cancer	4.15e-05	0.00201	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CDK4—hematologic cancer	4.09e-05	0.00198	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—MET—hematologic cancer	4.09e-05	0.00198	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—CCND1—hematologic cancer	4.05e-05	0.00197	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—CDKN1A—hematologic cancer	3.92e-05	0.0019	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—HDAC2—hematologic cancer	3.91e-05	0.0019	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—CASC3—hematologic cancer	3.82e-05	0.00186	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—EP300—hematologic cancer	3.73e-05	0.00181	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CREBBP—hematologic cancer	3.57e-05	0.00173	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—RB1—hematologic cancer	3.55e-05	0.00172	CbGpPWpGaD
Azacitidine—DNMT3A—RMTs methylate histone arginines—CCND1—hematologic cancer	3.53e-05	0.00171	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CDK2—hematologic cancer	3.47e-05	0.00168	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—ZNF552—hematologic cancer	3.41e-05	0.00165	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CDK4—hematologic cancer	3.28e-05	0.00159	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—MYC—hematologic cancer	3.25e-05	0.00158	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CDKN2A—hematologic cancer	3.12e-05	0.00152	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—MDM2—hematologic cancer	3.03e-05	0.00147	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—NCOR1—hematologic cancer	2.96e-05	0.00144	CbGpPWpGaD
Azacitidine—CDA—Metabolism—GMPS—hematologic cancer	2.85e-05	0.00138	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PHYH—hematologic cancer	2.85e-05	0.00138	CbGpPWpGaD
Azacitidine—CDA—Metabolism—FTCD—hematologic cancer	2.85e-05	0.00138	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—RB1—hematologic cancer	2.85e-05	0.00138	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CDKN1B—hematologic cancer	2.77e-05	0.00134	CbGpPWpGaD
Azacitidine—Adenosine triphosphate—ALK—hematologic cancer	2.71e-05	0.0235	CrCbGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CCND1—hematologic cancer	2.64e-05	0.00128	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—JUN—hematologic cancer	2.63e-05	0.00128	CbGpPWpGaD
Azacitidine—CDA—Metabolism—SMPD3—hematologic cancer	2.61e-05	0.00127	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—CASC3—hematologic cancer	2.58e-05	0.00125	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CDKN1A—hematologic cancer	2.55e-05	0.00124	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—RARS—hematologic cancer	2.46e-05	0.0012	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—EP300—hematologic cancer	2.43e-05	0.00118	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—MDM2—hematologic cancer	2.43e-05	0.00118	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—CDK4—hematologic cancer	2.33e-05	0.00113	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—POLR3E—hematologic cancer	2.32e-05	0.00112	CbGpPWpGaD
Azacitidine—CDA—Metabolism—B3GAT1—hematologic cancer	2.28e-05	0.00111	CbGpPWpGaD
Azacitidine—CDA—Metabolism—ASNS—hematologic cancer	2.28e-05	0.00111	CbGpPWpGaD
Azacitidine—CDA—Metabolism—DCK—hematologic cancer	2.28e-05	0.00111	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CDKN1B—hematologic cancer	2.22e-05	0.00108	CbGpPWpGaD
Azacitidine—CDA—Metabolism—HDC—hematologic cancer	2.16e-05	0.00105	CbGpPWpGaD
Azacitidine—Glucosamine—TNF—hematologic cancer	2.16e-05	0.0187	CrCbGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CCND1—hematologic cancer	2.12e-05	0.00103	CbGpPWpGaD
Azacitidine—Adenosine triphosphate—AKT1—hematologic cancer	2.11e-05	0.0183	CrCbGaD
Azacitidine—Adenosine monophosphate—SRC—hematologic cancer	2.08e-05	0.0181	CrCbGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CDKN1A—hematologic cancer	2.05e-05	0.000993	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—CREBBP—hematologic cancer	2.04e-05	0.000989	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—RARA—hematologic cancer	2.01e-05	0.000975	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—TET2—hematologic cancer	2.01e-05	0.000975	CbGpPWpGaD
Azacitidine—Adenosine triphosphate—ABL1—hematologic cancer	2e-05	0.0173	CrCbGaD
Azacitidine—DNMT3A—Gene Expression—RPLP1—hematologic cancer	1.97e-05	0.000956	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PC—hematologic cancer	1.9e-05	0.000923	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—NR0B2—hematologic cancer	1.87e-05	0.000906	CbGpPWpGaD
Azacitidine—Adenosine monophosphate—PDE4B—hematologic cancer	1.86e-05	0.0161	CrCbGaD
Azacitidine—CDA—Metabolism—SLC35B2—hematologic cancer	1.84e-05	0.000891	CbGpPWpGaD
Azacitidine—CDA—Metabolism—GBA—hematologic cancer	1.84e-05	0.000891	CbGpPWpGaD
Azacitidine—DNMT1—Budesonide—Dexamethasone—hematologic cancer	1.82e-05	0.028	CbGdCrCtD
Azacitidine—DNMT1—Budesonide—Betamethasone—hematologic cancer	1.82e-05	0.028	CbGdCrCtD
Azacitidine—Clofarabine—ABCG2—hematologic cancer	1.82e-05	0.0157	CrCbGaD
Azacitidine—DNMT1—Budesonide—Triamcinolone—hematologic cancer	1.78e-05	0.0274	CbGdCrCtD
Azacitidine—DNMT3A—Chromatin modifying enzymes—JAK2—hematologic cancer	1.77e-05	0.000861	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—ELL—hematologic cancer	1.76e-05	0.000852	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—MYC—hematologic cancer	1.7e-05	0.000824	CbGpPWpGaD
Azacitidine—DNMT1—Budesonide—Prednisone—hematologic cancer	1.69e-05	0.026	CbGdCrCtD
Azacitidine—DNMT3A—Gene Expression—NCOR2—hematologic cancer	1.69e-05	0.000818	CbGpPWpGaD
Azacitidine—CDA—Metabolism—MTAP—hematologic cancer	1.68e-05	0.000815	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—RARS—hematologic cancer	1.66e-05	0.000808	CbGpPWpGaD
Azacitidine—DNMT1—Budesonide—Prednisolone—hematologic cancer	1.65e-05	0.0254	CbGdCrCtD
Azacitidine—Cytarabine—SLC22A1—hematologic cancer	1.62e-05	0.0141	CrCbGaD
Azacitidine—DNMT1—Gene Expression—POLR3E—hematologic cancer	1.56e-05	0.000759	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—AGO2—hematologic cancer	1.55e-05	0.000754	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—H3F3B—hematologic cancer	1.52e-05	0.000739	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—DNMT3B—hematologic cancer	1.52e-05	0.000739	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—CCND1—hematologic cancer	1.51e-05	0.000732	CbGpPWpGaD
Azacitidine—CDA—Metabolism—FHL2—hematologic cancer	1.5e-05	0.000727	CbGpPWpGaD
Azacitidine—Cladribine—SLC22A1—hematologic cancer	1.49e-05	0.0129	CrCbGaD
Azacitidine—DNMT3A—Betamethasone—Dexamethasone—hematologic cancer	1.47e-05	0.0226	CbGdCrCtD
Azacitidine—DNMT3A—Dexamethasone—Betamethasone—hematologic cancer	1.47e-05	0.0226	CbGdCrCtD
Azacitidine—CDA—Metabolism—AGRN—hematologic cancer	1.47e-05	0.000713	CbGpPWpGaD
Azacitidine—DNMT3A—Dexamethasone—Triamcinolone—hematologic cancer	1.44e-05	0.0221	CbGdCrCtD
Azacitidine—DNMT3A—Betamethasone—Triamcinolone—hematologic cancer	1.44e-05	0.0221	CbGdCrCtD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—TP53—hematologic cancer	1.39e-05	0.000676	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—RPS14—hematologic cancer	1.39e-05	0.000676	CbGpPWpGaD
Azacitidine—CDA—Metabolism—IDH2—hematologic cancer	1.39e-05	0.000675	CbGpPWpGaD
Azacitidine—CDA—Metabolism—HMMR—hematologic cancer	1.39e-05	0.000675	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—EP300—hematologic cancer	1.39e-05	0.000674	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—NUP98—hematologic cancer	1.37e-05	0.000665	CbGpPWpGaD
Azacitidine—DNMT3A—Betamethasone—Prednisone—hematologic cancer	1.36e-05	0.021	CbGdCrCtD
Azacitidine—DNMT3A—Dexamethasone—Prednisone—hematologic cancer	1.36e-05	0.021	CbGdCrCtD
Azacitidine—DNMT1—Gene Expression—RARA—hematologic cancer	1.36e-05	0.000658	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—TET2—hematologic cancer	1.36e-05	0.000658	CbGpPWpGaD
Azacitidine—DNMT3A—Betamethasone—Prednisolone—hematologic cancer	1.33e-05	0.0205	CbGdCrCtD
Azacitidine—DNMT3A—Dexamethasone—Prednisolone—hematologic cancer	1.33e-05	0.0205	CbGdCrCtD
Azacitidine—DNMT1—Gene Expression—RPLP1—hematologic cancer	1.33e-05	0.000646	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—NUP214—hematologic cancer	1.32e-05	0.000641	CbGpPWpGaD
Azacitidine—CDA—Metabolism—ARNTL—hematologic cancer	1.31e-05	0.000635	CbGpPWpGaD
Azacitidine—CDA—Metabolism—CA9—hematologic cancer	1.27e-05	0.000618	CbGpPWpGaD
Azacitidine—CDA—Metabolism—ACP5—hematologic cancer	1.27e-05	0.000618	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—NR0B2—hematologic cancer	1.26e-05	0.000612	CbGpPWpGaD
Azacitidine—CDA—Metabolism—NCOR2—hematologic cancer	1.26e-05	0.00061	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—EIF4EBP1—hematologic cancer	1.22e-05	0.00059	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—HSPB1—hematologic cancer	1.22e-05	0.00059	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—DNMT3A—hematologic cancer	1.2e-05	0.000584	CbGpPWpGaD
Azacitidine—CDA—Metabolism—IDH1—hematologic cancer	1.2e-05	0.000581	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—ELL—hematologic cancer	1.19e-05	0.000575	CbGpPWpGaD
Azacitidine—CDA—Metabolism—TXN—hematologic cancer	1.18e-05	0.000574	CbGpPWpGaD
Azacitidine—CDA—Metabolism—ABCC3—hematologic cancer	1.18e-05	0.000574	CbGpPWpGaD
Azacitidine—CDA—Metabolism—GSTO1—hematologic cancer	1.18e-05	0.000574	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—SMC1A—hematologic cancer	1.16e-05	0.000565	CbGpPWpGaD
Azacitidine—CDA—Metabolism—SPHK1—hematologic cancer	1.16e-05	0.000562	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—H3F3A—hematologic cancer	1.14e-05	0.000554	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—NCOR2—hematologic cancer	1.14e-05	0.000552	CbGpPWpGaD
Azacitidine—DNMT1—Betamethasone—Dexamethasone—hematologic cancer	1.12e-05	0.0171	CbGdCrCtD
Azacitidine—DNMT1—Dexamethasone—Betamethasone—hematologic cancer	1.12e-05	0.0171	CbGdCrCtD
Azacitidine—CDA—Metabolism—UGT1A1—hematologic cancer	1.11e-05	0.00054	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—EZH2—hematologic cancer	1.1e-05	0.000532	CbGpPWpGaD
Azacitidine—DNMT1—Dexamethasone—Triamcinolone—hematologic cancer	1.09e-05	0.0167	CbGdCrCtD
Azacitidine—DNMT1—Betamethasone—Triamcinolone—hematologic cancer	1.09e-05	0.0167	CbGdCrCtD
Azacitidine—CDA—Metabolism—CRABP1—hematologic cancer	1.08e-05	0.000525	CbGpPWpGaD
Azacitidine—CDA—Metabolism—SLC22A1—hematologic cancer	1.08e-05	0.000525	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—PARP1—hematologic cancer	1.07e-05	0.00052	CbGpPWpGaD
Azacitidine—CDA—Metabolism—ALOX5—hematologic cancer	1.05e-05	0.000512	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—AGO2—hematologic cancer	1.05e-05	0.000509	CbGpPWpGaD
Azacitidine—Cladribine—ABCG2—hematologic cancer	1.04e-05	0.00904	CrCbGaD
Azacitidine—DNMT3A—Gene Expression—HDAC2—hematologic cancer	1.03e-05	0.000502	CbGpPWpGaD
Azacitidine—DNMT1—Dexamethasone—Prednisone—hematologic cancer	1.03e-05	0.0159	CbGdCrCtD
Azacitidine—DNMT1—Betamethasone—Prednisone—hematologic cancer	1.03e-05	0.0159	CbGdCrCtD
Azacitidine—DNMT1—Gene Expression—DNMT3B—hematologic cancer	1.03e-05	0.000499	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—H3F3B—hematologic cancer	1.03e-05	0.000499	CbGpPWpGaD
Azacitidine—CDA—Metabolism—NUP98—hematologic cancer	1.02e-05	0.000496	CbGpPWpGaD
Azacitidine—DNMT1—Betamethasone—Prednisolone—hematologic cancer	1.01e-05	0.0155	CbGdCrCtD
Azacitidine—DNMT1—Dexamethasone—Prednisolone—hematologic cancer	1.01e-05	0.0155	CbGdCrCtD
Azacitidine—CDA—Metabolism—ADCY7—hematologic cancer	9.92e-06	0.000481	CbGpPWpGaD
Azacitidine—CDA—Metabolism—NCOA3—hematologic cancer	9.92e-06	0.000481	CbGpPWpGaD
Azacitidine—CDA—Metabolism—NUP214—hematologic cancer	9.85e-06	0.000478	CbGpPWpGaD
Azacitidine—CDA—Metabolism—MTR—hematologic cancer	9.65e-06	0.000468	CbGpPWpGaD
Azacitidine—CDA—Metabolism—ABCG2—hematologic cancer	9.65e-06	0.000468	CbGpPWpGaD
Azacitidine—CDA—Metabolism—ENO2—hematologic cancer	9.46e-06	0.000459	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—RPS14—hematologic cancer	9.4e-06	0.000456	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—NUP98—hematologic cancer	9.25e-06	0.000449	CbGpPWpGaD
Azacitidine—CDA—Metabolism—GSTT1—hematologic cancer	9.17e-06	0.000445	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—AR—hematologic cancer	8.97e-06	0.000435	CbGpPWpGaD
Azacitidine—CDA—Metabolism—SDC1—hematologic cancer	8.97e-06	0.000435	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—NUP214—hematologic cancer	8.92e-06	0.000433	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—CDKN2B—hematologic cancer	8.26e-06	0.000401	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—HSPB1—hematologic cancer	8.22e-06	0.000399	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—EIF4EBP1—hematologic cancer	8.22e-06	0.000399	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—SMC1A—hematologic cancer	7.87e-06	0.000382	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—NCOR1—hematologic cancer	7.84e-06	0.000381	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—H3F3A—hematologic cancer	7.71e-06	0.000374	CbGpPWpGaD
Azacitidine—CDA—Metabolism—NQO1—hematologic cancer	7.62e-06	0.00037	CbGpPWpGaD
Azacitidine—CDA—Metabolism—CD44—hematologic cancer	7.62e-06	0.00037	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—EZH2—hematologic cancer	7.4e-06	0.000359	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—NR3C1—hematologic cancer	7.25e-06	0.000352	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—PARP1—hematologic cancer	7.24e-06	0.000352	CbGpPWpGaD
Azacitidine—CDA—Metabolism—CYCS—hematologic cancer	7.21e-06	0.00035	CbGpPWpGaD
Azacitidine—CDA—Metabolism—HSP90AA1—hematologic cancer	7.17e-06	0.000348	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—HDAC2—hematologic cancer	6.99e-06	0.000339	CbGpPWpGaD
Azacitidine—Gemcitabine—ABCB1—hematologic cancer	6.91e-06	0.00599	CrCbGaD
Azacitidine—CDA—Metabolism—GSTP1—hematologic cancer	6.36e-06	0.000309	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—MAPK14—hematologic cancer	6.28e-06	0.000305	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—ESR1—hematologic cancer	6.16e-06	0.000299	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—AR—hematologic cancer	6.06e-06	0.000294	CbGpPWpGaD
Azacitidine—CDA—Metabolism—ABCB1—hematologic cancer	6.02e-06	0.000292	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—NOTCH1—hematologic cancer	5.95e-06	0.000289	CbGpPWpGaD
Azacitidine—CDA—Metabolism—NCOR1—hematologic cancer	5.84e-06	0.000284	CbGpPWpGaD
Azacitidine—CDA—Metabolism—GSTM1—hematologic cancer	5.84e-06	0.000284	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—CDKN2B—hematologic cancer	5.58e-06	0.000271	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—CREBBP—hematologic cancer	5.4e-06	0.000262	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—NCOR1—hematologic cancer	5.3e-06	0.000257	CbGpPWpGaD
Azacitidine—CDA—Metabolism—MTHFR—hematologic cancer	5.16e-06	0.000251	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—NR3C1—hematologic cancer	4.9e-06	0.000238	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PIK3CG—hematologic cancer	4.34e-06	0.000211	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—MAPK14—hematologic cancer	4.24e-06	0.000206	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—ESR1—hematologic cancer	4.16e-06	0.000202	CbGpPWpGaD
Azacitidine—CDA—Metabolism—CREBBP—hematologic cancer	4.02e-06	0.000195	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—NOTCH1—hematologic cancer	4.02e-06	0.000195	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PIK3CD—hematologic cancer	3.81e-06	0.000185	CbGpPWpGaD
Azacitidine—CDA—Metabolism—ALB—hematologic cancer	3.77e-06	0.000183	CbGpPWpGaD
Azacitidine—Adenosine triphosphate—ABCB1—hematologic cancer	3.69e-06	0.0032	CrCbGaD
Azacitidine—DNMT1—Gene Expression—CREBBP—hematologic cancer	3.65e-06	0.000177	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PIK3R1—hematologic cancer	3.6e-06	0.000175	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PIK3CB—hematologic cancer	3.32e-06	0.000161	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—MAPK3—hematologic cancer	3.29e-06	0.00016	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—MYC—hematologic cancer	3.2e-06	0.000155	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PTEN—hematologic cancer	2.87e-06	0.000139	CbGpPWpGaD
Azacitidine—CDA—Metabolism—EP300—hematologic cancer	2.74e-06	0.000133	CbGpPWpGaD
Azacitidine—Fatigue—Dexamethasone—hematologic cancer	2.65e-06	5.67e-05	CcSEcCtD
Azacitidine—Fatigue—Betamethasone—hematologic cancer	2.65e-06	5.67e-05	CcSEcCtD
Azacitidine—Chills—Epirubicin—hematologic cancer	2.65e-06	5.66e-05	CcSEcCtD
Azacitidine—Pruritus—Etoposide—hematologic cancer	2.64e-06	5.65e-05	CcSEcCtD
Azacitidine—Shock—Prednisone—hematologic cancer	2.63e-06	5.64e-05	CcSEcCtD
Azacitidine—Pain—Betamethasone—hematologic cancer	2.63e-06	5.62e-05	CcSEcCtD
Azacitidine—Pain—Dexamethasone—hematologic cancer	2.63e-06	5.62e-05	CcSEcCtD
Azacitidine—Nervous system disorder—Prednisone—hematologic cancer	2.63e-06	5.62e-05	CcSEcCtD
Azacitidine—Tachycardia—Prednisone—hematologic cancer	2.61e-06	5.59e-05	CcSEcCtD
Azacitidine—Alopecia—Epirubicin—hematologic cancer	2.61e-06	5.57e-05	CcSEcCtD
Azacitidine—Skin disorder—Prednisone—hematologic cancer	2.6e-06	5.56e-05	CcSEcCtD
Azacitidine—Nausea—Gemcitabine—hematologic cancer	2.6e-06	5.56e-05	CcSEcCtD
Azacitidine—Vomiting—Cisplatin—hematologic cancer	2.59e-06	5.55e-05	CcSEcCtD
Azacitidine—Hyperhidrosis—Prednisone—hematologic cancer	2.59e-06	5.54e-05	CcSEcCtD
Azacitidine—Mental disorder—Epirubicin—hematologic cancer	2.58e-06	5.52e-05	CcSEcCtD
Azacitidine—Rash—Cisplatin—hematologic cancer	2.57e-06	5.5e-05	CcSEcCtD
Azacitidine—Dermatitis—Cisplatin—hematologic cancer	2.57e-06	5.5e-05	CcSEcCtD
Azacitidine—Erythema—Epirubicin—hematologic cancer	2.57e-06	5.49e-05	CcSEcCtD
Azacitidine—Malnutrition—Epirubicin—hematologic cancer	2.57e-06	5.49e-05	CcSEcCtD
Azacitidine—Diarrhoea—Etoposide—hematologic cancer	2.56e-06	5.47e-05	CcSEcCtD
Azacitidine—Anorexia—Prednisone—hematologic cancer	2.55e-06	5.46e-05	CcSEcCtD
Azacitidine—Eye disorder—Doxorubicin—hematologic cancer	2.55e-06	5.45e-05	CcSEcCtD
Azacitidine—Ill-defined disorder—Methotrexate—hematologic cancer	2.54e-06	5.44e-05	CcSEcCtD
Azacitidine—Anaemia—Methotrexate—hematologic cancer	2.53e-06	5.42e-05	CcSEcCtD
Azacitidine—Feeling abnormal—Betamethasone—hematologic cancer	2.53e-06	5.42e-05	CcSEcCtD
Azacitidine—Feeling abnormal—Dexamethasone—hematologic cancer	2.53e-06	5.42e-05	CcSEcCtD
Azacitidine—Cardiac disorder—Doxorubicin—hematologic cancer	2.53e-06	5.42e-05	CcSEcCtD
Azacitidine—Gastrointestinal pain—Betamethasone—hematologic cancer	2.51e-06	5.38e-05	CcSEcCtD
Azacitidine—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.51e-06	5.38e-05	CcSEcCtD
Azacitidine—Hypersensitivity—Triamcinolone—hematologic cancer	2.5e-06	5.34e-05	CcSEcCtD
Azacitidine—Back pain—Epirubicin—hematologic cancer	2.48e-06	5.31e-05	CcSEcCtD
Azacitidine—Angiopathy—Doxorubicin—hematologic cancer	2.47e-06	5.29e-05	CcSEcCtD
Azacitidine—Malaise—Methotrexate—hematologic cancer	2.47e-06	5.29e-05	CcSEcCtD
Azacitidine—Dizziness—Etoposide—hematologic cancer	2.47e-06	5.29e-05	CcSEcCtD
Azacitidine—Muscle spasms—Epirubicin—hematologic cancer	2.47e-06	5.28e-05	CcSEcCtD
Azacitidine—Immune system disorder—Doxorubicin—hematologic cancer	2.46e-06	5.27e-05	CcSEcCtD
Azacitidine—Mediastinal disorder—Doxorubicin—hematologic cancer	2.46e-06	5.26e-05	CcSEcCtD
Azacitidine—Leukopenia—Methotrexate—hematologic cancer	2.45e-06	5.25e-05	CcSEcCtD
Azacitidine—Chills—Doxorubicin—hematologic cancer	2.45e-06	5.24e-05	CcSEcCtD
Azacitidine—Urticaria—Dexamethasone—hematologic cancer	2.44e-06	5.23e-05	CcSEcCtD
Azacitidine—Urticaria—Betamethasone—hematologic cancer	2.44e-06	5.23e-05	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.44e-06	5.22e-05	CcSEcCtD
Azacitidine—Dizziness—Prednisolone—hematologic cancer	2.44e-06	5.21e-05	CcSEcCtD
Azacitidine—Asthenia—Triamcinolone—hematologic cancer	2.43e-06	5.2e-05	CcSEcCtD
Azacitidine—Abdominal pain—Betamethasone—hematologic cancer	2.43e-06	5.2e-05	CcSEcCtD
Azacitidine—Body temperature increased—Betamethasone—hematologic cancer	2.43e-06	5.2e-05	CcSEcCtD
Azacitidine—Body temperature increased—Dexamethasone—hematologic cancer	2.43e-06	5.2e-05	CcSEcCtD
Azacitidine—Abdominal pain—Dexamethasone—hematologic cancer	2.43e-06	5.2e-05	CcSEcCtD
Azacitidine—Nausea—Cisplatin—hematologic cancer	2.42e-06	5.18e-05	CcSEcCtD
Azacitidine—Insomnia—Prednisone—hematologic cancer	2.42e-06	5.18e-05	CcSEcCtD
Azacitidine—Alopecia—Doxorubicin—hematologic cancer	2.41e-06	5.16e-05	CcSEcCtD
Azacitidine—Pruritus—Triamcinolone—hematologic cancer	2.4e-06	5.13e-05	CcSEcCtD
Azacitidine—Cough—Methotrexate—hematologic cancer	2.39e-06	5.12e-05	CcSEcCtD
Azacitidine—Mental disorder—Doxorubicin—hematologic cancer	2.39e-06	5.11e-05	CcSEcCtD
Azacitidine—Ill-defined disorder—Epirubicin—hematologic cancer	2.38e-06	5.09e-05	CcSEcCtD
Azacitidine—Convulsion—Methotrexate—hematologic cancer	2.38e-06	5.08e-05	CcSEcCtD
Azacitidine—Vomiting—Etoposide—hematologic cancer	2.38e-06	5.08e-05	CcSEcCtD
Azacitidine—Erythema—Doxorubicin—hematologic cancer	2.37e-06	5.08e-05	CcSEcCtD
Azacitidine—Malnutrition—Doxorubicin—hematologic cancer	2.37e-06	5.08e-05	CcSEcCtD
Azacitidine—Anaemia—Epirubicin—hematologic cancer	2.37e-06	5.07e-05	CcSEcCtD
Azacitidine—Dyspepsia—Prednisone—hematologic cancer	2.36e-06	5.04e-05	CcSEcCtD
Azacitidine—Rash—Etoposide—hematologic cancer	2.36e-06	5.04e-05	CcSEcCtD
Azacitidine—Dermatitis—Etoposide—hematologic cancer	2.35e-06	5.03e-05	CcSEcCtD
Azacitidine—Headache—Etoposide—hematologic cancer	2.34e-06	5.01e-05	CcSEcCtD
Azacitidine—Chest pain—Methotrexate—hematologic cancer	2.33e-06	4.99e-05	CcSEcCtD
Azacitidine—Myalgia—Methotrexate—hematologic cancer	2.33e-06	4.99e-05	CcSEcCtD
Azacitidine—Arthralgia—Methotrexate—hematologic cancer	2.33e-06	4.99e-05	CcSEcCtD
Azacitidine—Decreased appetite—Prednisone—hematologic cancer	2.33e-06	4.98e-05	CcSEcCtD
Azacitidine—Rash—Prednisolone—hematologic cancer	2.32e-06	4.97e-05	CcSEcCtD
Azacitidine—Dermatitis—Prednisolone—hematologic cancer	2.32e-06	4.97e-05	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.32e-06	4.96e-05	CcSEcCtD
Azacitidine—Malaise—Epirubicin—hematologic cancer	2.31e-06	4.95e-05	CcSEcCtD
Azacitidine—Fatigue—Prednisone—hematologic cancer	2.31e-06	4.94e-05	CcSEcCtD
Azacitidine—Headache—Prednisolone—hematologic cancer	2.31e-06	4.94e-05	CcSEcCtD
Azacitidine—Discomfort—Methotrexate—hematologic cancer	2.31e-06	4.93e-05	CcSEcCtD
Azacitidine—Syncope—Epirubicin—hematologic cancer	2.3e-06	4.92e-05	CcSEcCtD
Azacitidine—Leukopenia—Epirubicin—hematologic cancer	2.3e-06	4.91e-05	CcSEcCtD
Azacitidine—Back pain—Doxorubicin—hematologic cancer	2.3e-06	4.91e-05	CcSEcCtD
Azacitidine—Constipation—Prednisone—hematologic cancer	2.29e-06	4.9e-05	CcSEcCtD
Azacitidine—Muscle spasms—Doxorubicin—hematologic cancer	2.28e-06	4.88e-05	CcSEcCtD
Azacitidine—Confusional state—Methotrexate—hematologic cancer	2.26e-06	4.83e-05	CcSEcCtD
Azacitidine—Loss of consciousness—Epirubicin—hematologic cancer	2.26e-06	4.82e-05	CcSEcCtD
Azacitidine—Dizziness—Triamcinolone—hematologic cancer	2.24e-06	4.79e-05	CcSEcCtD
Azacitidine—Cough—Epirubicin—hematologic cancer	2.24e-06	4.79e-05	CcSEcCtD
Azacitidine—Anaphylactic shock—Methotrexate—hematologic cancer	2.24e-06	4.79e-05	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—MAPK3—hematologic cancer	2.22e-06	0.000108	CbGpPWpGaD
Azacitidine—Convulsion—Epirubicin—hematologic cancer	2.22e-06	4.76e-05	CcSEcCtD
Azacitidine—Infection—Methotrexate—hematologic cancer	2.22e-06	4.76e-05	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—AKT1—hematologic cancer	2.22e-06	0.000108	CbGpPWpGaD
Azacitidine—Nausea—Etoposide—hematologic cancer	2.22e-06	4.75e-05	CcSEcCtD
Azacitidine—Hypertension—Epirubicin—hematologic cancer	2.22e-06	4.74e-05	CcSEcCtD
Azacitidine—Feeling abnormal—Prednisone—hematologic cancer	2.21e-06	4.72e-05	CcSEcCtD
Azacitidine—Asthenia—Dexamethasone—hematologic cancer	2.21e-06	4.72e-05	CcSEcCtD
Azacitidine—Asthenia—Betamethasone—hematologic cancer	2.21e-06	4.72e-05	CcSEcCtD
Azacitidine—Ill-defined disorder—Doxorubicin—hematologic cancer	2.2e-06	4.71e-05	CcSEcCtD
Azacitidine—Nervous system disorder—Methotrexate—hematologic cancer	2.19e-06	4.69e-05	CcSEcCtD
Azacitidine—Anaemia—Doxorubicin—hematologic cancer	2.19e-06	4.69e-05	CcSEcCtD
Azacitidine—Thrombocytopenia—Methotrexate—hematologic cancer	2.19e-06	4.69e-05	CcSEcCtD
Azacitidine—Gastrointestinal pain—Prednisone—hematologic cancer	2.19e-06	4.68e-05	CcSEcCtD
Azacitidine—Nausea—Prednisolone—hematologic cancer	2.19e-06	4.68e-05	CcSEcCtD
Azacitidine—Myalgia—Epirubicin—hematologic cancer	2.18e-06	4.67e-05	CcSEcCtD
Azacitidine—Chest pain—Epirubicin—hematologic cancer	2.18e-06	4.67e-05	CcSEcCtD
Azacitidine—Arthralgia—Epirubicin—hematologic cancer	2.18e-06	4.67e-05	CcSEcCtD
Azacitidine—Anxiety—Epirubicin—hematologic cancer	2.18e-06	4.66e-05	CcSEcCtD
Azacitidine—Pruritus—Betamethasone—hematologic cancer	2.18e-06	4.65e-05	CcSEcCtD
Azacitidine—Pruritus—Dexamethasone—hematologic cancer	2.18e-06	4.65e-05	CcSEcCtD
Azacitidine—Skin disorder—Methotrexate—hematologic cancer	2.17e-06	4.65e-05	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.17e-06	4.64e-05	CcSEcCtD
Azacitidine—Hyperhidrosis—Methotrexate—hematologic cancer	2.16e-06	4.63e-05	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—MYC—hematologic cancer	2.16e-06	0.000105	CbGpPWpGaD
Azacitidine—Discomfort—Epirubicin—hematologic cancer	2.16e-06	4.62e-05	CcSEcCtD
Azacitidine—Vomiting—Triamcinolone—hematologic cancer	2.15e-06	4.61e-05	CcSEcCtD
Azacitidine—Malaise—Doxorubicin—hematologic cancer	2.14e-06	4.58e-05	CcSEcCtD
Azacitidine—Rash—Triamcinolone—hematologic cancer	2.14e-06	4.57e-05	CcSEcCtD
Azacitidine—Dermatitis—Triamcinolone—hematologic cancer	2.13e-06	4.57e-05	CcSEcCtD
Azacitidine—Anorexia—Methotrexate—hematologic cancer	2.13e-06	4.56e-05	CcSEcCtD
Azacitidine—Syncope—Doxorubicin—hematologic cancer	2.13e-06	4.55e-05	CcSEcCtD
Azacitidine—Urticaria—Prednisone—hematologic cancer	2.13e-06	4.55e-05	CcSEcCtD
Azacitidine—Leukopenia—Doxorubicin—hematologic cancer	2.13e-06	4.55e-05	CcSEcCtD
Azacitidine—Headache—Triamcinolone—hematologic cancer	2.12e-06	4.54e-05	CcSEcCtD
Azacitidine—Body temperature increased—Prednisone—hematologic cancer	2.12e-06	4.53e-05	CcSEcCtD
Azacitidine—Abdominal pain—Prednisone—hematologic cancer	2.12e-06	4.53e-05	CcSEcCtD
Azacitidine—Confusional state—Epirubicin—hematologic cancer	2.11e-06	4.52e-05	CcSEcCtD
Azacitidine—Diarrhoea—Dexamethasone—hematologic cancer	2.1e-06	4.5e-05	CcSEcCtD
Azacitidine—Diarrhoea—Betamethasone—hematologic cancer	2.1e-06	4.5e-05	CcSEcCtD
Azacitidine—Anaphylactic shock—Epirubicin—hematologic cancer	2.09e-06	4.48e-05	CcSEcCtD
Azacitidine—Oedema—Epirubicin—hematologic cancer	2.09e-06	4.48e-05	CcSEcCtD
Azacitidine—Hypotension—Methotrexate—hematologic cancer	2.09e-06	4.47e-05	CcSEcCtD
Azacitidine—Loss of consciousness—Doxorubicin—hematologic cancer	2.09e-06	4.46e-05	CcSEcCtD
Azacitidine—Infection—Epirubicin—hematologic cancer	2.08e-06	4.45e-05	CcSEcCtD
Azacitidine—Cough—Doxorubicin—hematologic cancer	2.07e-06	4.43e-05	CcSEcCtD
Azacitidine—Shock—Epirubicin—hematologic cancer	2.06e-06	4.41e-05	CcSEcCtD
Azacitidine—Convulsion—Doxorubicin—hematologic cancer	2.06e-06	4.4e-05	CcSEcCtD
Azacitidine—Nervous system disorder—Epirubicin—hematologic cancer	2.05e-06	4.39e-05	CcSEcCtD
Azacitidine—Thrombocytopenia—Epirubicin—hematologic cancer	2.05e-06	4.39e-05	CcSEcCtD
Azacitidine—Hypertension—Doxorubicin—hematologic cancer	2.05e-06	4.39e-05	CcSEcCtD
Azacitidine—Tachycardia—Epirubicin—hematologic cancer	2.04e-06	4.37e-05	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.04e-06	4.36e-05	CcSEcCtD
Azacitidine—Skin disorder—Epirubicin—hematologic cancer	2.03e-06	4.35e-05	CcSEcCtD
Azacitidine—Dizziness—Betamethasone—hematologic cancer	2.03e-06	4.35e-05	CcSEcCtD
Azacitidine—Dizziness—Dexamethasone—hematologic cancer	2.03e-06	4.35e-05	CcSEcCtD
Azacitidine—CDA—Metabolism—PIK3CA—hematologic cancer	2.03e-06	9.84e-05	CbGpPWpGaD
Azacitidine—Hyperhidrosis—Epirubicin—hematologic cancer	2.02e-06	4.33e-05	CcSEcCtD
Azacitidine—Insomnia—Methotrexate—hematologic cancer	2.02e-06	4.33e-05	CcSEcCtD
Azacitidine—Chest pain—Doxorubicin—hematologic cancer	2.02e-06	4.32e-05	CcSEcCtD
Azacitidine—Myalgia—Doxorubicin—hematologic cancer	2.02e-06	4.32e-05	CcSEcCtD
Azacitidine—Arthralgia—Doxorubicin—hematologic cancer	2.02e-06	4.32e-05	CcSEcCtD
Azacitidine—Anxiety—Doxorubicin—hematologic cancer	2.01e-06	4.31e-05	CcSEcCtD
Azacitidine—Nausea—Triamcinolone—hematologic cancer	2.01e-06	4.31e-05	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.01e-06	4.29e-05	CcSEcCtD
Azacitidine—Discomfort—Doxorubicin—hematologic cancer	2e-06	4.27e-05	CcSEcCtD
Azacitidine—Anorexia—Epirubicin—hematologic cancer	2e-06	4.27e-05	CcSEcCtD
Azacitidine—Dyspnoea—Methotrexate—hematologic cancer	2e-06	4.27e-05	CcSEcCtD
Azacitidine—Hypersensitivity—Prednisone—hematologic cancer	1.97e-06	4.22e-05	CcSEcCtD
Azacitidine—Dyspepsia—Methotrexate—hematologic cancer	1.97e-06	4.21e-05	CcSEcCtD
Azacitidine—Hypotension—Epirubicin—hematologic cancer	1.96e-06	4.19e-05	CcSEcCtD
Azacitidine—Vomiting—Betamethasone—hematologic cancer	1.96e-06	4.18e-05	CcSEcCtD
Azacitidine—Vomiting—Dexamethasone—hematologic cancer	1.96e-06	4.18e-05	CcSEcCtD
Azacitidine—Confusional state—Doxorubicin—hematologic cancer	1.95e-06	4.18e-05	CcSEcCtD
Azacitidine—Decreased appetite—Methotrexate—hematologic cancer	1.95e-06	4.16e-05	CcSEcCtD
Azacitidine—Rash—Dexamethasone—hematologic cancer	1.94e-06	4.15e-05	CcSEcCtD
Azacitidine—Rash—Betamethasone—hematologic cancer	1.94e-06	4.15e-05	CcSEcCtD
Azacitidine—Anaphylactic shock—Doxorubicin—hematologic cancer	1.94e-06	4.15e-05	CcSEcCtD
Azacitidine—Oedema—Doxorubicin—hematologic cancer	1.94e-06	4.15e-05	CcSEcCtD
Azacitidine—Dermatitis—Betamethasone—hematologic cancer	1.94e-06	4.14e-05	CcSEcCtD
Azacitidine—Dermatitis—Dexamethasone—hematologic cancer	1.94e-06	4.14e-05	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.93e-06	4.13e-05	CcSEcCtD
Azacitidine—Fatigue—Methotrexate—hematologic cancer	1.93e-06	4.13e-05	CcSEcCtD
Azacitidine—Headache—Dexamethasone—hematologic cancer	1.93e-06	4.12e-05	CcSEcCtD
Azacitidine—Headache—Betamethasone—hematologic cancer	1.93e-06	4.12e-05	CcSEcCtD
Azacitidine—Infection—Doxorubicin—hematologic cancer	1.93e-06	4.12e-05	CcSEcCtD
Azacitidine—Asthenia—Prednisone—hematologic cancer	1.92e-06	4.11e-05	CcSEcCtD
Azacitidine—Pain—Methotrexate—hematologic cancer	1.91e-06	4.09e-05	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.91e-06	4.08e-05	CcSEcCtD
Azacitidine—Shock—Doxorubicin—hematologic cancer	1.91e-06	4.08e-05	CcSEcCtD
Azacitidine—Nervous system disorder—Doxorubicin—hematologic cancer	1.9e-06	4.07e-05	CcSEcCtD
Azacitidine—Thrombocytopenia—Doxorubicin—hematologic cancer	1.9e-06	4.06e-05	CcSEcCtD
Azacitidine—Pruritus—Prednisone—hematologic cancer	1.89e-06	4.05e-05	CcSEcCtD
Azacitidine—Insomnia—Epirubicin—hematologic cancer	1.89e-06	4.05e-05	CcSEcCtD
Azacitidine—Tachycardia—Doxorubicin—hematologic cancer	1.89e-06	4.05e-05	CcSEcCtD
Azacitidine—Skin disorder—Doxorubicin—hematologic cancer	1.88e-06	4.03e-05	CcSEcCtD
Azacitidine—Hyperhidrosis—Doxorubicin—hematologic cancer	1.87e-06	4.01e-05	CcSEcCtD
Azacitidine—Dyspnoea—Epirubicin—hematologic cancer	1.87e-06	3.99e-05	CcSEcCtD
Azacitidine—Anorexia—Doxorubicin—hematologic cancer	1.85e-06	3.95e-05	CcSEcCtD
Azacitidine—Feeling abnormal—Methotrexate—hematologic cancer	1.84e-06	3.95e-05	CcSEcCtD
Azacitidine—Dyspepsia—Epirubicin—hematologic cancer	1.84e-06	3.94e-05	CcSEcCtD
Azacitidine—Diarrhoea—Prednisone—hematologic cancer	1.83e-06	3.92e-05	CcSEcCtD
Azacitidine—Gastrointestinal pain—Methotrexate—hematologic cancer	1.83e-06	3.91e-05	CcSEcCtD
Azacitidine—Nausea—Dexamethasone—hematologic cancer	1.83e-06	3.91e-05	CcSEcCtD
Azacitidine—Nausea—Betamethasone—hematologic cancer	1.83e-06	3.91e-05	CcSEcCtD
Azacitidine—Decreased appetite—Epirubicin—hematologic cancer	1.82e-06	3.89e-05	CcSEcCtD
Azacitidine—Hypotension—Doxorubicin—hematologic cancer	1.81e-06	3.87e-05	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.81e-06	3.87e-05	CcSEcCtD
Azacitidine—Fatigue—Epirubicin—hematologic cancer	1.81e-06	3.86e-05	CcSEcCtD
Azacitidine—Pain—Epirubicin—hematologic cancer	1.79e-06	3.83e-05	CcSEcCtD
Azacitidine—Constipation—Epirubicin—hematologic cancer	1.79e-06	3.83e-05	CcSEcCtD
Azacitidine—Urticaria—Methotrexate—hematologic cancer	1.78e-06	3.8e-05	CcSEcCtD
Azacitidine—Dizziness—Prednisone—hematologic cancer	1.77e-06	3.79e-05	CcSEcCtD
Azacitidine—Abdominal pain—Methotrexate—hematologic cancer	1.77e-06	3.78e-05	CcSEcCtD
Azacitidine—Body temperature increased—Methotrexate—hematologic cancer	1.77e-06	3.78e-05	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.77e-06	3.78e-05	CcSEcCtD
Azacitidine—Insomnia—Doxorubicin—hematologic cancer	1.75e-06	3.75e-05	CcSEcCtD
Azacitidine—Dyspnoea—Doxorubicin—hematologic cancer	1.73e-06	3.7e-05	CcSEcCtD
Azacitidine—Feeling abnormal—Epirubicin—hematologic cancer	1.73e-06	3.69e-05	CcSEcCtD
Azacitidine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.71e-06	3.66e-05	CcSEcCtD
Azacitidine—Dyspepsia—Doxorubicin—hematologic cancer	1.71e-06	3.65e-05	CcSEcCtD
Azacitidine—Vomiting—Prednisone—hematologic cancer	1.7e-06	3.64e-05	CcSEcCtD
Azacitidine—Rash—Prednisone—hematologic cancer	1.69e-06	3.61e-05	CcSEcCtD
Azacitidine—Dermatitis—Prednisone—hematologic cancer	1.69e-06	3.61e-05	CcSEcCtD
Azacitidine—Decreased appetite—Doxorubicin—hematologic cancer	1.68e-06	3.6e-05	CcSEcCtD
Azacitidine—Headache—Prednisone—hematologic cancer	1.68e-06	3.59e-05	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.67e-06	3.58e-05	CcSEcCtD
Azacitidine—Fatigue—Doxorubicin—hematologic cancer	1.67e-06	3.57e-05	CcSEcCtD
Azacitidine—Urticaria—Epirubicin—hematologic cancer	1.66e-06	3.56e-05	CcSEcCtD
Azacitidine—Constipation—Doxorubicin—hematologic cancer	1.66e-06	3.54e-05	CcSEcCtD
Azacitidine—Pain—Doxorubicin—hematologic cancer	1.66e-06	3.54e-05	CcSEcCtD
Azacitidine—CDA—Metabolism—AKT1—hematologic cancer	1.66e-06	8.04e-05	CbGpPWpGaD
Azacitidine—Body temperature increased—Epirubicin—hematologic cancer	1.66e-06	3.54e-05	CcSEcCtD
Azacitidine—Abdominal pain—Epirubicin—hematologic cancer	1.66e-06	3.54e-05	CcSEcCtD
Azacitidine—Hypersensitivity—Methotrexate—hematologic cancer	1.65e-06	3.53e-05	CcSEcCtD
Azacitidine—Asthenia—Methotrexate—hematologic cancer	1.61e-06	3.43e-05	CcSEcCtD
Azacitidine—Feeling abnormal—Doxorubicin—hematologic cancer	1.6e-06	3.42e-05	CcSEcCtD
Azacitidine—Nausea—Prednisone—hematologic cancer	1.59e-06	3.4e-05	CcSEcCtD
Azacitidine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.58e-06	3.39e-05	CcSEcCtD
Azacitidine—Pruritus—Methotrexate—hematologic cancer	1.58e-06	3.39e-05	CcSEcCtD
Azacitidine—Hypersensitivity—Epirubicin—hematologic cancer	1.54e-06	3.3e-05	CcSEcCtD
Azacitidine—Urticaria—Doxorubicin—hematologic cancer	1.54e-06	3.29e-05	CcSEcCtD
Azacitidine—Abdominal pain—Doxorubicin—hematologic cancer	1.53e-06	3.28e-05	CcSEcCtD
Azacitidine—Body temperature increased—Doxorubicin—hematologic cancer	1.53e-06	3.28e-05	CcSEcCtD
Azacitidine—Diarrhoea—Methotrexate—hematologic cancer	1.53e-06	3.28e-05	CcSEcCtD
Azacitidine—Asthenia—Epirubicin—hematologic cancer	1.5e-06	3.21e-05	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—AKT1—hematologic cancer	1.5e-06	7.28e-05	CbGpPWpGaD
Azacitidine—Pruritus—Epirubicin—hematologic cancer	1.48e-06	3.17e-05	CcSEcCtD
Azacitidine—Dizziness—Methotrexate—hematologic cancer	1.48e-06	3.17e-05	CcSEcCtD
Azacitidine—Diarrhoea—Epirubicin—hematologic cancer	1.43e-06	3.07e-05	CcSEcCtD
Azacitidine—Hypersensitivity—Doxorubicin—hematologic cancer	1.43e-06	3.05e-05	CcSEcCtD
Azacitidine—Vomiting—Methotrexate—hematologic cancer	1.42e-06	3.04e-05	CcSEcCtD
Azacitidine—Rash—Methotrexate—hematologic cancer	1.41e-06	3.02e-05	CcSEcCtD
Azacitidine—Dermatitis—Methotrexate—hematologic cancer	1.41e-06	3.02e-05	CcSEcCtD
Azacitidine—Headache—Methotrexate—hematologic cancer	1.4e-06	3e-05	CcSEcCtD
Azacitidine—Asthenia—Doxorubicin—hematologic cancer	1.39e-06	2.97e-05	CcSEcCtD
Azacitidine—Dizziness—Epirubicin—hematologic cancer	1.39e-06	2.96e-05	CcSEcCtD
Azacitidine—Pruritus—Doxorubicin—hematologic cancer	1.37e-06	2.93e-05	CcSEcCtD
Azacitidine—Vomiting—Epirubicin—hematologic cancer	1.33e-06	2.85e-05	CcSEcCtD
Azacitidine—Nausea—Methotrexate—hematologic cancer	1.33e-06	2.84e-05	CcSEcCtD
Azacitidine—Diarrhoea—Doxorubicin—hematologic cancer	1.33e-06	2.84e-05	CcSEcCtD
Azacitidine—Rash—Epirubicin—hematologic cancer	1.32e-06	2.82e-05	CcSEcCtD
Azacitidine—Dermatitis—Epirubicin—hematologic cancer	1.32e-06	2.82e-05	CcSEcCtD
Azacitidine—Headache—Epirubicin—hematologic cancer	1.31e-06	2.81e-05	CcSEcCtD
Azacitidine—Dizziness—Doxorubicin—hematologic cancer	1.28e-06	2.74e-05	CcSEcCtD
Azacitidine—Nausea—Epirubicin—hematologic cancer	1.24e-06	2.66e-05	CcSEcCtD
Azacitidine—Vomiting—Doxorubicin—hematologic cancer	1.23e-06	2.64e-05	CcSEcCtD
Azacitidine—Rash—Doxorubicin—hematologic cancer	1.22e-06	2.61e-05	CcSEcCtD
Azacitidine—Dermatitis—Doxorubicin—hematologic cancer	1.22e-06	2.61e-05	CcSEcCtD
Azacitidine—Headache—Doxorubicin—hematologic cancer	1.21e-06	2.6e-05	CcSEcCtD
Azacitidine—Nausea—Doxorubicin—hematologic cancer	1.15e-06	2.46e-05	CcSEcCtD
